A track record of success.
In 1987, Chirag, Chintu and their father Kanu, an industrial pharmacist, immigrated to the United States. Now, with college degrees in the states and a business environment that rewarded entrepreneurship, the family worked together on a shared vision to create a company that drove superb business results while contributing to the betterment of society. In 2002, the family formed Amneal Pharmaceuticals as a small, private generics company. Through both organic and inorganic growth, Amneal is now one of the leading generic and specialty pharmaceutical companies in the US. Amneal is increasing the global reach of affordable generic versions of leading drugs and helping more people access life-changing cures and treatments.
Continued investment in broadening the portfolio of companies.
In addition to Amneal, the family has invested over $1 billion in family capital building a broad range of companies ranging from biotech to health technology, and from concept to commercialization. View Our Companies.
From early stage to industry leadership.
At Avtar, our mission is to continue this legacy of growing successful companies by helping our partners leverage their full potential. We offer expert counsel, strategy development, and senior industry access to help you get the most from every aspect of your team’s skills and experience. As successful business builders, we understand the life cycle of growing companies—their ups and downs, challenges, and opportunities. We are unique in that we invest across all phases of the life cycle of a company, eliminating the problem of continually raising capital that growing companies face.
